Your browser doesn't support javascript.
loading
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
Vergote, I; González-Martín, A; Ray-Coquard, I; Harter, P; Colombo, N; Pujol, P; Lorusso, D; Mirza, M R; Brasiuniene, B; Madry, R; Brenton, J D; Ausems, M G E M; Büttner, R; Lambrechts, D.
Afiliação
  • Vergote I; Division of Gynaecological Oncology, Department of Gynaecology and Obstetrics and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be.
  • González-Martín A; Clinica Universidad de Navarra, Madrid, Spain; Program for Solid Tumors at Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.
  • Ray-Coquard I; Medical Oncology, Centre Leon Bérard and Université Claude Bernard Lyon, Lyon, France.
  • Harter P; Department of Gynaecology & Gynaecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.
  • Colombo N; University of Milan-Bicocca and European Institute of Oncology IRCCS, Milan, Italy.
  • Pujol P; Montpellier Faculty of Medicine, University Hospital of Montpellier, Montpellier, France.
  • Lorusso D; Department of Women and Child Science and Public Health, Catholic University of Rome, Fondazione Policlinico Gemelli IRCCS, Rome, Italy.
  • Mirza MR; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Brasiuniene B; Department of Medical Oncology, National Cancer Institute of Lithuania, Faculty of Medicine of Vilnius University, Vilnius, Lithuania.
  • Madry R; Oncological Gynaecology Department, Poznan University of Medical Sciences, Poznan, Poland.
  • Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Ausems MGEM; Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Büttner R; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
  • Lambrechts D; Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium.
Ann Oncol ; 33(3): 276-287, 2022 03.
Article em En | MEDLINE | ID: mdl-34861371
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article